Using Chitosan or Chitosan Derivatives in Cancer Therapy

• Published in: Polysaccharides Vol. 2; no. 4; pp. 795 - 816
• Main Authors: Shakil, Md Salman, Mahmud, Kazi Mustafa, Sayem, Mohammad, Niloy, Mahruba Sultana, Halder, Sajal Kumar, Hossen, Md. Sakib, Uddin, Md. Forhad, Hasan, Md. Ashraful
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-12-2021
• Subjects: anticancer activities; Antimicrobial agents; Antitumor agents; Apoptosis; Bioavailability; Biocompatibility; Biopolymers; Breast cancer; Cancer; Cancer therapies; Cell cycle; Cellulose; Chitin; Chitosan; chitosan derivatives; Cytotoxicity; Drug delivery; Drug delivery systems; Drug dosages; Drug resistance; gene and drug delivery; Gene expression; Growth factors; immunotherapy; Kinases; Ligands; Molecular weight; Nanocomposites; Nanoparticles; Pharmaceutical industry; Polyethylene glycol; Tumor necrosis factor-TNF; Vitamin B
• ISSN: 2673-4176; 2673-4176
• DOI: 10.3390/polysaccharides2040048

Cancer is one of the major causes of death worldwide. Chemotherapeutic drugs have become a popular choice as anticancer agents. Despite the therapeutic benefits of chemotherapeutic drugs, patients often experience side effects and drug resistance. Biopolymers could be used to overcome some of the limitations of chemotherapeutic drugs, as well as be used either as anticancer agents or drug delivery vehicles. Chitosan is a biocompatible polymer derived from chitin. Chitosan, chitosan derivatives, or chitosan nanoparticles have shown their promise as an anticancer agent. Additionally, functionally modified chitosan can be used to deliver nucleic acids, chemotherapeutic drugs, and anticancer agents. More importantly, chitosan-based drug delivery systems improved the efficacy, potency, cytotoxicity, or biocompatibility of these anticancer agents. In this review, we will investigate the properties of chitosan and chemically tuned chitosan derivatives, and their application in cancer therapy.